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Radiation Oncology is a dynamic and evolving field. 
Professionals need to find efficient and effective ways to stay 
informed of the latest developments, to collaborate and 
exchange knowledge with others, and to update or acquire 
new skills and competences.  
E-Learning is an excellent way to achieve this. E-Learning is 
defined as the use of information and communication 
technologies to enable learning and performance. It has the 
potential to help radiation oncologists around the world to 
develop their competences whenever they want, at any time; 
allowing them to tailor their learning experiences to their 
goals, preferences, and needs.  
This lecture will introduce the concept of e-Learning and its 
role for professional development in Radiation Oncology. It 
will present practical examples and strategies for young 
scientist to stay updated with recent findings and guidelines 
in the field, to develop their competences, and to find peers 
and opportunities for collaboration. 
 
Symposium with Proffered Papers: Quality beyond 
accuracy: are we failing to see the forest for the trees?  
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We will define ‘accuracy’ as delivering the desired radiation 
dose to the target whilst minimising as much dose as possible 
to the surrounding normal tissues, thus embracing the 
classical balance which must be achieved with all 
radiotherapy.  
The process begins with identifying the target, and therefore 
includes improving imaging for target volume delineation. 
Nevertheless, considerable uncertainties still exist especially 
in the personalisation of the Clinical Target Volume (CTV). 
Better conformation of dose to target shape has been a long 
term objective, beginning even in the ortho-voltage era. The 
biggest step, a revolutionary change, was the introduction of 
3D conformal RT. IMRT represents ‘ultra-conformal’ 
treatment. Use of proton and carbon ion beams represents 
further steps along this path.  
Improving accuracy also includes ensuring that today’s highly 
conformal treatment plans are actually delivered to the 
target, without missing, and not to surrounding normal 
tissues. This brings us to image guidance, which appears to 
be vital, especially with steep dose gradient IMRT plans, but 
which is difficult (perhaps impossible) to test using the 
conventional trial paradigms.  
A further concept is that the planned dose may differ from 
the accumulated delivered dose (DA), as the result of patient 
or tumour changes. Computational developments mean that 
individual patient DA can be estimated in a research setting 
using daily image guidance scans, so that clinical 
implementation will need to be addressed.  
An additional development is the use of real time imaging 
during the exposure to monitor patient or organ movement, 
using X-ray or MRI approaches.  
In terms of clinical outcomes, good evidence exists that 
better imaging improves outcomes. The introduction of 3D 
CRT, perhaps the most important step of all, has a strong 
evidence base. IMRT is also supported by strong clinical 
evidence. There is highly suggestive evidence that charged 
particle beams have a valuable role. Sadly, there is also good 
evidence that bad quality in plan preparation and delivery 
leads to worse local control and survival (TROG). Image 
guidance is a more challenging component of the 
radiotherapy chain for which to provide hard trial evidence, 
although it has a clear rationale.  
Overall, there is a definitive evidence base that better 
accuracy improves outcomes for both tumour control and 
normal tissue sparing using current technologies. Additional 
opportunities are also developing, making this is a truly 
exciting time to be working in radiation oncology. 
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Beyond the technological advances to improve radiation 
therapy, the patient can also actively participate in its care 
process and contribute to ameliorate its management. The 
patient is a key player in security and improvement care 
processes. The patient’s needs and expectations can be 
harvested through satisfaction surveys, adverse event 
declarations, records of complaints and patient committee.  
An important place in our Radiotherapy Department is given 
to harvesting and processing patient’s opinions to add value 
for it. In order to know the views of patients on the quality of 
our services and help us to improve it, we have developed a 
survey covering 6 themes. Figure 1 shows the surveys’ results 
of the last three years for the 6 themes, which are close or 
greater than the institutional goal. 
 
 
A patient committee is under construction. This committee, 
including former treated patients, will meet to discuss the 
satisfaction rates and improvement actions. 
We also collect complaints and unexpected events. These are 
declared on adverse event reports. These reports are 
investigated during Experience feedback committee (EFBC).  
Through these different channels the patient is actively 
involved in the quality processes of the Radiotherapy 
